On 9th March came the announcement that tazemetostat (Tazverik) is being voluntarily withdrawn worldwide. Ipsen, the company that markets tazemetostat, ...
NICE has approved epcoritamab (Tepkinly) on the NHS for adults in England, Wales and Northern Ireland with relapsed or refractory ...
This International Women’s Day the FLF and our global community are proud to celebrate and highlight the exceptional women whose ...
Could your health data help improve care for people living with follicular lymphoma? Join our free webinar with lymphoma expert ...
In this “Science Simplified” series, we’ll be sharing insights from the latest research presented at the American Society of Hematology (ASH) ...
Being a doctor and an oncology patient at the same time was a really strange experience. I was in disbelief ...
